Uni Prot Comments Displayer
Protein Atlas Displayer
Gene Expression Atlas Tissues Displayer
Gene Expression Atlas Diseases Displayer
Publication Counts Displayer
Curated Proteins Displayer
Function
Gene Ontology Displayer
40 Pathways
- Metabolism of proteins,
- Misspliced GSK3beta mutants stabilize beta-catenin,
- AXIN missense mutants destabilize the destruction complex,
- Signaling by WNT,
- Endometrial cancer,
- truncated APC mutants destabilize the destruction complex,
- Estrogen-dependent gene expression,
- Ub-specific processing proteases,
- Signal Transduction,
- Gene expression (Transcription),
- RUNX1 regulates estrogen receptor mediated transcription,
- phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,
- Disassembly of the destruction complex and recruitment of AXIN to the membrane,
- Post-translational protein modification,
- Wnt signaling pathway,
- AXIN mutants destabilize the destruction complex, activating WNT signaling,
- Disease,
- ESR-mediated signaling,
- AMER1 mutants destabilize the destruction complex,
- Degradation of AXIN,
- Signaling by WNT in cancer,
- APC truncation mutants have impaired AXIN binding,
- Colorectal cancer,
- RNA Polymerase II Transcription,
- Degradation of beta-catenin by the destruction complex,
- Generic Transcription Pathway,
- RUNX1 regulates transcription of genes involved in WNT signaling,
- Transcriptional regulation by RUNX1,
- S37 mutants of beta-catenin aren't phosphorylated,
- T41 mutants of beta-catenin aren't phosphorylated,
- Beta-catenin phosphorylation cascade,
- Pathways in cancer,
- S33 mutants of beta-catenin aren't phosphorylated,
- Basal cell carcinoma,
- Truncations of AMER1 destabilize the destruction complex,
- Diseases of signal transduction by growth factor receptors and second messengers,
- S45 mutants of beta-catenin aren't phosphorylated,
- TCF dependent signaling in response to WNT,
- Signaling by Nuclear Receptors,
- Deubiquitination
Gene --> GO terms.
Gene -> HPO annotation (Human Phenotype Ontology)
Mouse Gene --> Allele [Phenotype]
Genomics
J Browse Displayer
Gene Structure Displayer
Overlapping Features Displayer
Mouse Alleles Displayer
Gene --> Chromosomal location.
Gene --> GO terms.
Gene --> Overlapping genes.
Disease
Gene (Hum OR Rat) --> Mouse Allele (Phenotype)
Gene --> Alleles and Disease (clinVar data)
Gene -> HPO annotation (Human Phenotype Ontology)
Mouse Gene --> Allele [Phenotype]
Other
40 Pathways
- Metabolism of proteins,
- Misspliced GSK3beta mutants stabilize beta-catenin,
- AXIN missense mutants destabilize the destruction complex,
- Signaling by WNT,
- Endometrial cancer,
- truncated APC mutants destabilize the destruction complex,
- Estrogen-dependent gene expression,
- Ub-specific processing proteases,
- Signal Transduction,
- Gene expression (Transcription),
- RUNX1 regulates estrogen receptor mediated transcription,
- phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,
- Disassembly of the destruction complex and recruitment of AXIN to the membrane,
- Post-translational protein modification,
- Wnt signaling pathway,
- AXIN mutants destabilize the destruction complex, activating WNT signaling,
- Disease,
- ESR-mediated signaling,
- AMER1 mutants destabilize the destruction complex,
- Degradation of AXIN,
- Signaling by WNT in cancer,
- APC truncation mutants have impaired AXIN binding,
- Colorectal cancer,
- RNA Polymerase II Transcription,
- Degradation of beta-catenin by the destruction complex,
- Generic Transcription Pathway,
- RUNX1 regulates transcription of genes involved in WNT signaling,
- Transcriptional regulation by RUNX1,
- S37 mutants of beta-catenin aren't phosphorylated,
- T41 mutants of beta-catenin aren't phosphorylated,
- Beta-catenin phosphorylation cascade,
- Pathways in cancer,
- S33 mutants of beta-catenin aren't phosphorylated,
- Basal cell carcinoma,
- Truncations of AMER1 destabilize the destruction complex,
- Diseases of signal transduction by growth factor receptors and second messengers,
- S45 mutants of beta-catenin aren't phosphorylated,
- TCF dependent signaling in response to WNT,
- Signaling by Nuclear Receptors,
- Deubiquitination
